Intrauterine Adhesion Clinical Trial
Official title:
Assessment of Uterine Access, Uterine Patency and Intrauterine Adhesions (IUA) 3, 6 and 12 Months Following Endometrial Ablation: A Prospective Single-Center Observational Study
NCT number | NCT04824430 |
Other study ID # | EA 21-001 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | March 23, 2021 |
Est. completion date | July 22, 2021 |
Verified date | June 2022 |
Source | Rejoni Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The objective of this study is to gain information concerning the acute and longer-term morphological changes within the uterus following endometrial ablation. Hysteroscopic evaluation of the uterine cavity will be used to determine if physical access and the ability to systematically assess the post-ablation uterine cavity were preserved. The presence, location and severity of intrauterine adhesions will be documented in participants who are 3, 6 and 12 months from their standard of care endometrial ablation.
Status | Completed |
Enrollment | 36 |
Est. completion date | July 22, 2021 |
Est. primary completion date | July 22, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Premenopausal female patients = 18 years of age - Patient has undergone endometrial ablation within the prior 14 months. - There were no contraindications for endometrial ablation as specified in Ablation System labeling - Patient agrees to undergo an SLH either at 3, 6 or 12 months post-ablation - Patient abstained from any form of hormonal contraception including an IUD after the ablation and through the period that the SLH is performed. - Patient has signed the IRB approved informed consent. Exclusion Criteria: - Additional intrauterine procedures performed between time of endometrial ablation and the SLH; e.g., endometrial and/or myometrial resection. - IUD in situ - Pregnant (positive urine pregnancy test) or lactating - Active sexually transmitted infection or genital infection, or other clinically significant active and/or systemic infection per clinical or laboratory examinations at the time of endometrial ablation procedure or second look hysteroscopy (e.g., cervicitis, vaginitis, endometritis, or salpingitis). - Systemic steroid within 1 week of endometrial ablation - Previous adhesiolysis procedure or diagnosis of Asherman's disease. - No noted clinically significant uterine anomalies at the time of the ablation (e.g., septate uterus or other anomalies that distorts the uterine cavity) - Any other condition that in the opinion of the investigator could represent an increased risk for the subject, affect the primary outcomes of this study and/or impact the subject's ability to comply with protocol requirements. - Participating or considering participation in a clinical trial of another investigational drug or device during this study |
Country | Name | City | State |
---|---|---|---|
United States | Basinksi and Juran, MD's | Newburgh | Indiana |
Lead Sponsor | Collaborator |
---|---|
Rejoni Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of Intrauterine Adhesions (IUA) | 3, 6 or 12 months post-ablation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04972032 -
Efficacy of Estrogen-intrauterine Stent System After Intrauterine Adhesiolysis
|
N/A | |
Recruiting |
NCT03381807 -
Human Amniotic Epithelial Stem Cell in Treatment of Refractory Severe Intrauterine Adhesion
|
Early Phase 1 | |
Recruiting |
NCT03329898 -
Comparing the Efficacy of Two Methods for the Therapy of Uterine Adhesion
|
N/A | |
Completed |
NCT03724617 -
Clinical Study of Umbilical Cord Mesenchymal Stem Cells Combined With Collagen Scaffold in the Treatment of Thin Endometrium
|
N/A | |
Recruiting |
NCT03330873 -
The Efficacy and Safety of Disposable Balloon Uterine Stent in Patients With Asherman Syndrome
|
N/A | |
Completed |
NCT02220621 -
Efficacy and Safety of Crosslinked Hyaluronan Gel for Preventing Intrauterine Adhesion
|
N/A | |
Active, not recruiting |
NCT04963179 -
PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.
|
N/A | |
Recruiting |
NCT03351205 -
The Efficacy of Estrogen Therapy Against Adhesion Reformation After Hysteroscopic Adhesiolysis
|
N/A | |
Completed |
NCT04381728 -
PREvention of Intrauterine Adhesion After Hysteroscopic Surgery With Novel deGradable Film
|
N/A | |
Recruiting |
NCT03346317 -
Comparing the Efficacy of Two Methods in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis
|
N/A | |
Completed |
NCT05414760 -
Evaluate Formation of IUAs After Third-generation Endometrial Ablation, With and Without Intrauterine Adhesion Barrier
|
N/A | |
Completed |
NCT04166500 -
Early Outpatient Hysteroscopy Can Prevent Intrauterine Adhesion After Induced Abortion
|
N/A | |
Recruiting |
NCT03169478 -
Intrauterine Balloon Dilatation Therapy in the Prevention of Adhesion Formation After Hysteroscopic Myomectomy
|
N/A | |
Recruiting |
NCT03171454 -
Immediate and Delayed Intrauterine Balloon in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis
|
N/A | |
Recruiting |
NCT05003869 -
Clinical and Basic Research on the Necessity of Scar Tissue Resection During Intrauterine Adhesions
|
N/A | |
Completed |
NCT02744716 -
Effects of Aspirin on Uterine Endometrial Repair Severe Intrauterine Adhesion
|
N/A | |
Completed |
NCT03131596 -
Postoperative Intermittent Intrauterine Balloon Dilatation Therapy.
|
N/A | |
Completed |
NCT01167296 -
Safety of Leaving Cook Balloon Uterine Stent in Uterus for One Month
|
Phase 4 | |
Completed |
NCT03578172 -
HMG Stimulation Versus HRT for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe IUA Patients
|
N/A | |
Recruiting |
NCT04930913 -
Three-dimensional Ultrasound Applying in Assessment of Intrauterine Adhesions
|